Contrastingly, GLP1 antagonist sales in 2023 showcase a more diversified landscape, with therapeutics such as Ozempic, Trulicity, and Mounjaro driving 71 per cent of the sales. Looking ahead, the GLP1 agonist market is poised for robust growth, anticipating a 19.2 per cent compound annual growth rate (CAGR) from 2023 to 2029, reaching a substantial market size of $105 billion in 2029
Glutathione can be supplemented in a variety of ways, including through your diet, inhaled, injected intramuscularly or intravenously, and orally through pills
As many patients receive medication supplies greater than one month, it will be important to continue to track these trends
Bupropion and Naltrexone in Methamphetamine Use Disorder (ADAPT-2)